Hong Kong Looks To EU For New Advanced Therapy Rules
Executive Summary
Hong Kong is consulting on proposals to include advanced therapies in its regulatory framework for pharmaceuticals.
You may also be interested in...
Scrutiny In Store For Hong Kong’s First Advanced Therapy Rules
Requirements for advanced therapies in Hong Kong are being modeled on the EU regulatory regime.
Scrutiny In Store For Hong Kong’s First Advanced Therapy Rules
Requirements for advanced therapies in Hong Kong are being modeled on the EU regulatory regime.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.